Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry

Autor: López-Sainz Á, Salazar-Mendiguchía J, García-Álvarez A, Campuzano Larrea O, López-Garrido MÁ, García-Guereta L, Fuentes Cañamero ME, Climent Payá V, Peña-Peña ML, Zorio-Grima E, Jordá-Burgos P, Díez-López C, Brugada R, García-Pinilla JM, García-Pavía P

Publikováno v: REVISTA ESPANOLA DE CARDIOLOGIA
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

Introduction and objectives: Danon disease (DD) is caused by mutations in the LAMP2 gene. It is considered a multisystemic disease characterized by hypertrophic cardiomyopathy with pre-excitation and extreme hypertrophy, intellectual disability, myop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0077ecf953cdb261ed40e23de40e7a07
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3076

Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception.

Autor: Roa-Colomo A; Clinical Medicine and Public Health Doctoral Program, University of Granada, Granada, Spain.; Gastroenterology and Hepatology Department, San Cecilio University Hospital, Granada, Spain., López Garrido MÁ; Gastroenterology and Hepatology Department, Virgen De Las Nieves University Hospital, Granada, Spain., Molina-Vallejo P; Genyo-Centro Pfizer-Universidad De Granada-Junta De Andalucía De Genómica e Investigación Oncológica, Granada, Spain., Rojas A; Seliver Group, Institute of Biomedicine of Seville (IBiS)/ Hospital Universitario Virgen Del Rocío/CSIC/Universidad De Sevilla, Seville, Spain.; Spanish Network for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute (ISCIII), Madrid, Spain., Sanchez MG; Gastroenterology and Hepatology Department, Virgen De Las Nieves University Hospital, Granada, Spain., Aranda-García V; Statistician at Fundación para la Investigación Biosanitaria Andalucía Oriental Alejandro Otero (FIBAO), Hospital Virgen de las Nieves, Granada, Spain., Salmeron J; Gastroenterology and Hepatology Department, San Cecilio University Hospital, Granada, Spain., Romero-Gomez M; Seliver Group, Institute of Biomedicine of Seville (IBiS)/ Hospital Universitario Virgen Del Rocío/CSIC/Universidad De Sevilla, Seville, Spain.; Spanish Network for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute (ISCIII), Madrid, Spain., Muntane J; Spanish Network for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute (ISCIII), Madrid, Spain.; Institute of Biomedicine of Seville (IBiS), Hospital University Virgen del Rocío/CSIC/University of Seville, Seville, Spain.; Department of Medical Physiology and Biophysics, University of Seville, Seville, Spain., Padillo J; General and Gastrointestinal Surgery Division, Virgen del Rocío University Hospital, Sevilla, Spain., Alamo JM; General and Gastrointestinal Surgery Division, Virgen del Rocío University Hospital, Sevilla, Spain., Lorente JA; Genyo-Centro Pfizer-Universidad De Granada-Junta De Andalucía De Genómica e Investigación Oncológica, Granada, Spain.; Legal Medicine Department, Medicine School, University of Granada, Granada, Spain., Serrano MJ; Genyo-Centro Pfizer-Universidad De Granada-Junta De Andalucía De Genómica e Investigación Oncológica, Granada, Spain.; Comprehensive Oncology Division, Clinical University Hospital, Virgen de las Nieves-IBS, Granada, Spain.; Department of Pathological Anatomy, Faculty of Medicine, University of Granada, Granada, Spain., Garrido-Navas MC; Genyo-Centro Pfizer-Universidad De Granada-Junta De Andalucía De Genómica e Investigación Oncológica, Granada, Spain.

Publikováno v: Frontiers in molecular biosciences [Front Mol Biosci] 2022 Nov 28; Vol. 9, pp. 1074277. Date of Electronic Publication: 2022 Nov 28 (Print Publication: 2022).

Autoimmune severe acute fulminant hepatic failure (FHF) during pregnancy.

Autor: Caballero-Mateos AM; Servicio de Aparato Digestivo y Hepatología, Hospital Virgen de las Nieves, Granada, España. Electronic address: ogy1492@hotmail.com., López Garrido MÁ; Servicio de Aparato Digestivo y Hepatología, Hospital Virgen de las Nieves, Granada, España., Becerra Massare P; Servicio de Anatomía Patológica, Hospital Virgen de las Nieves, Granada, España., de Teresa Galván J; Servicio de Aparato Digestivo y Hepatología, Hospital Virgen de las Nieves, Granada, España.

Publikováno v: Gastroenterologia y hepatologia [Gastroenterol Hepatol] 2018 Apr; Vol. 41 (4), pp. 259-260. Date of Electronic Publication: 2017 Jun 02.